Results 221 to 230 of about 15,950 (247)

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Cost-effectiveness of artificial intelligence interventions for musculoskeletal disorders of the spine: a systematic review. [PDF]

Rheumatol Int
Gebrye T, Mbada C, Niyi-Odumosu F, Fatoye C, Odetunde M, Hakimi Z, Useh U, Fatoye F.   +7 more
europepmc   +1 more source

Effectiveness and Safety of Mud Therapy (Pelotherapy) for Musculoskeletal Disorders: A Systematic Review and Meta-Analysis. [PDF]

J Lifestyle Med
Balakrishna S, Hansoge Manjanna P, Mudalahippe Kumaraswamy N, Metty V, Singh AK, Kottapalla Bhaskaran A.   +5 more
europepmc   +1 more source

Philippine Clinical Practice Guidelines for Periodic Health Examination: Screening for Musculoskeletal Disorders. [PDF]

Acta Med Philipp
Osio-Salido E, Mendoza NRNP, Reyes BHM, Orillaza NS, Leochico CFD, Burog AILD, Bayona HHG, Chan KJC, Espino VLA, Francisco MDD, Infantado-Alejandro MAJ, King REC, Villanueva CAG, Zamora MKS, Salido ITO, Philippine Periodic Health Examination Task Force on Screening for Musculoskeletal Disorders.   +15 more
europepmc   +1 more source

Musculoskeletal Disorders and the Hotel Industry: A Cross-Sectional Survey. [PDF]

Cureus
Gherscovici ED, Mayer JM.
europepmc   +1 more source

Socioeconomic deprivation and risk of early-onset pre-eclampsia in England: a national population-based cohort study

Phillips E, Caretta Cortegiani F, Aiken C, Knight M, Kajaria-Montag H, Orfanoudaki A, Zhong Y.   +6 more
europepmc   +1 more source

Economic impact of musculoskeletal disorders (MSDs) on work in Europe

Best Practice and Research in Clinical Rheumatology, 2015
Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, ‘presenteeism’ and loss of productivity across all the European Union (EU) member states.
Stephen Bevan
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Work-related psychosocial and physical paths to future musculoskeletal disorders (MSDs)

Safety Science, 2023
Ha Nguyen, Maureen Dollard, Richard W. Morris   +2 more
exaly  

Prevalence of musculoskeletal disorders (MSDS) among primary school female teachers in Terengganu, Malaysia

International Journal of Industrial Ergonomics, 2020
Karmegam Karuppiah, Vivien How
exaly